Dynavax Technologies Corporation [NASDAQ: DVAX] price plunged by -3.82 percent to reach at -$0.24. A sum of 4266797 shares traded at recent session while its average daily volume was at 5.11M shares. Dynavax Technologies Corporation shares reached a high of $6.52 and dropped to a low of $5.955 until finishing in the latest session at $6.18.
Guru’s Opinion on Dynavax Technologies Corporation [DVAX]:
Evercore ISI have made an estimate for Dynavax Technologies Corporation shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on June 15, 2020. While these analysts kept the previous recommendation, H.C. Wainwright raised their target price to Buy. The new note on the price target was released on October 18, 2019, representing the official price target for Dynavax Technologies Corporation stock. Previously, the target price had yet another raise to $20, while Cantor Fitzgerald analysts kept a Overweight rating on DVAX stock. On February 27, 2019, analysts decreased their price target for DVAX shares from 32 to 28.
The Average True Range (ATR) for Dynavax Technologies Corporation is set at 0.74, with the Price to Sales ratio for DVAX stock in the period of the last 12 months amounting to 14.71. The Price to Book ratio for the last quarter was 44.11, with the Price to Cash per share for the same quarter was set at 1.35.
DVAX Stock Performance Analysis:
Dynavax Technologies Corporation [DVAX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 5.02. With this latest performance, DVAX shares gained by 35.71% in over the last four-week period, additionally sinking by -10.77% over the last 6 months – not to mention a rise of 50.61% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for DVAX stock in for the last two-week period is set at 55.89, with the RSI for the last a single of trading hit 54.28, and the three-weeks RSI is set at 55.98 for Dynavax Technologies Corporation [DVAX]. The present Moving Average for the last 50 days of trading for this stock 4.67, while it was recorded at 5.93 for the last single week of trading, and 4.82 for the last 200 days.
Insight into Dynavax Technologies Corporation Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Dynavax Technologies Corporation [DVAX] shares currently have an operating margin of -338.44 and a Gross Margin at +27.47. Dynavax Technologies Corporation’s Net Margin is presently recorded at -433.29.
Return on Total Capital for DVAX is now -60.86, given the latest momentum, and Return on Invested Capital for the company is -78.52. Return on Equity for this stock declined to -427.72, with Return on Assets sitting at -62.29. When it comes to the capital structure of this company, Dynavax Technologies Corporation [DVAX] has a Total Debt to Total Equity ratio set at 2,647.59. Additionally, DVAX Total Debt to Total Capital is recorded at 96.36, with Total Debt to Total Assets ending up at 78.65. Long-Term Debt to Equity for the company is recorded at 2,610.93, with the Long-Term Debt to Total Capital now at 95.03.
Reflecting on the efficiency of the workforce at the company, Dynavax Technologies Corporation [DVAX] managed to generate an average of -$660,606 per employee. Receivables Turnover for the company is 5.59 with a Total Asset Turnover recorded at a value of 0.14.Dynavax Technologies Corporation’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.00 and a Current Ratio set at 6.60.
DVAX Stock EPS
With the latest financial reports released by the company, Dynavax Technologies Corporation posted -0.66/share EPS, while the average EPS was predicted by analysts to be reported at -0.56/share.When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -17.90%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for DVAX.
Dynavax Technologies Corporation [DVAX] Insider Position Details
There are presently around $397 million, or 61.50% of DVAX stock, in the hands of institutional investors. The top three institutional holders of DVAX stocks are: FEDERATED HERMES, INC. with ownership of 9,766,800, which is approximately 5.624% of the company’s market cap and around 0.50% of the total institutional ownership; BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC, holding 8,730,707 shares of the stock with an approximate value of $56.05 million in DVAX stocks shares; and BLACKROCK INC., currently with $38.3 million in DVAX stock with ownership of nearly -3.488% of the company’s market capitalization.
Positions in Dynavax Technologies Corporation stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 54 institutional holders increased their position in Dynavax Technologies Corporation [NASDAQ:DVAX] by around 6,244,979 shares. Additionally, 52 investors decreased positions by around 9,815,769 shares, while 28 investors held positions by with 45,749,976 shares. The mentioned changes placed institutional holdings at 61,810,724 shares, according to the latest SEC report filing. DVAX stock had 14 new institutional investments in for a total of 479,300 shares, while 21 institutional investors sold positions of 7,548,658 shares during the same period.